kitio.aiInsilico Medicine vs Unlearn
A side-by-side look at pricing plans, free tiers, features, pros and cons, updated for 2026. Insilico Medicine starts at See pricing page and Unlearn starts at See pricing page. Check both pricing pages for current plans.
At a glance
Best for
Pricing model
Starting price
Free plan
Made by
Based in
Rating
Key features
- PandaOmics target discovery
- Chemistry42 molecule design
- Generative Biologics
- inClinico trial prediction
- DORA research assistant
- MCP servers for agents
- Participant digital twins
- Trial design simulation
- Interim analysis support
- Digital twin comparators
- Regulatory strategy expertise
| Feature | Insilico Medicine | Unlearn |
|---|---|---|
| Best for | Generative AI software for drug discovery and clinical research | Digital twins of trial participants for clinical development |
| Category | Legal, finance & HR | Legal, finance & HR |
| Pricing model | Paid | Paid |
| Starting price | See pricing page | See pricing page |
| Free plan | No | No |
| Made by | Insilico Medicine | Unlearn |
| Based in | – | – |
| Rating | No ratings yet | No ratings yet |
| Key features |
|
|
Pricing compared
Insilico Medicine starts at See pricing page and Unlearn starts at See pricing page. Check both pricing pages for current plans.
Free plan
Cheapest paid plan
Top plan
Free trial
Prices in USD, checked Oct 29, 2026 or later. Plans change often, so confirm on each tool's site before you buy.
Pros and cons
Insilico Medicine
- Covers target discovery through trial design
- Backed by its own drug pipeline
- Agent access through MCP
- No public pricing
- Built for pharma and biotech experts
- Sales process needed to get access
Unlearn
- Targets specific decisions across the trial lifecycle
- Can support smaller study designs
- Works for randomized and single-arm studies
- Enterprise service, no self-serve sign-up
- No published pricing
- Aimed only at clinical development teams
Which one should you choose?
Choose Insilico Medicine if you want:
- Covers target discovery through trial design
- Backed by its own drug pipeline
- Agent access through MCP
Watch out: no public pricing.
Choose Unlearn if you want:
- Targets specific decisions across the trial lifecycle
- Can support smaller study designs
- Works for randomized and single-arm studies
Watch out: enterprise service, no self-serve sign-up.
Insilico Medicine vs Unlearn FAQ
What is the difference between Insilico Medicine and Unlearn?
Insilico Medicine: Generative AI software for drug discovery and clinical research. Unlearn: Digital twins of trial participants for clinical development. Both are legal, finance & hr tools.
Is Insilico Medicine or Unlearn cheaper?
Insilico Medicine starts at See pricing page and Unlearn starts at See pricing page. Check both pricing pages for current plans.
Do Insilico Medicine and Unlearn have free plans?
Insilico Medicine: No. Unlearn: No.
Who makes Insilico Medicine?
Insilico Medicine is made by Insilico Medicine.
Who makes Unlearn?
Unlearn is made by Unlearn.
Which should I choose, Insilico Medicine or Unlearn?
Choose Insilico Medicine if you value covers target discovery through trial design and backed by its own drug pipeline. Choose Unlearn if you value targets specific decisions across the trial lifecycle and can support smaller study designs.